Loading
Loading…
Loading…
Tender Value
₹1.4 Cr
EMD Value
Exempted
Closing Date
4 Sept 2026, 3:00 pm
IFA 19 RE DRUGS
9675912
GEM/2026/B/7847325
Two Packet Bid
Tab Ivosidenib 250 mg,Tab Letermovir 240 mg,Zanubrutinib 80 mg Tab,LEVILACTOBACILLUS BREVIS CD2,Tab
Lucknow, Uttar Pradesh
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹68 L
₹2.8 Cr
10%
PCDA, PCDA Lucknow, Department of Military Affairs, Indian Army, Ministry of Defence, (Pcda Lucknow)
Exempted
Yes
21 Aug 2026
21 Aug 2026
4 Sept 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Tab Ivosidenib 250 mg | 720 | No | DGLPMS | 30 |
| 2 | Tab Letermovir 240 mg | 720 | No | DGLPMS | 30 |
| 3 | Zanubrutinib 80 mg Tab | 720 | No | DGLPMS | 30 |
| 4 | LEVILACTOBACILLUS BREVIS CD2 | 660 | No | DGLPMS | 30 |
| 5 | Tab Ciprofloxacin 500 mg with Tinidazole 600 mg | 3,900 | No | DGLPMS | 30 |
| 6 | Fluconazole 150mg Cap oblique Tab | 5,400 | No | DGLPMS | 30 |
| 7 | Ceftriaxone 1000mg with Sulbactum 500mg Inj | 4,200 | VIAL | DGLPMS | 30 |
| 8 | Metronidazole IP 200 mg Tab | 2,880 | No | DGLPMS | 30 |
| 9 | Aceclofenac 100mg with Paracetamol 325mg Tab | 4,500 | No | DGLPMS | 30 |
| 10 | Onco BCG Vaccine Intraversical 40 mg inj | 36 | VIAL | DGLPMS | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9675912.pdf
GEM_BID • 0.20 MB
bbqr_2026-07-29-10-22-00_2c5eba590184cd4598bf418ddc4bffa2.pdf
BOQ • 0.38 MB
boq_item_sample_file_2026-07-29-10-22-00_9a75e73e430447136fd126605ef33adc.csv
BOQ • 0.00 MB
BBQR_5a737005-a941-4ace-89931785301583592_MSPCmemb2.pdf
GEM_OTHER • 0.38 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].